AstraZeneca drug evaluated in nine eosinophilic diseases
April 23, 2021Medical Communications AstraZeneca
AstraZeneca announced on Thursday that the first patients had been dosed in the Phase III Fasenra (benralizumab) clinical trial in …
Lipidor to begin Phase III trial on psoriasis treatment
April 22, 2021Phase III trials, lipidor, pharma, pharma news, psoriasis
Lipidor has submitted an application with the Indian Medical Products Agency to begin a Phase III trial on their drug …
Novo Nordisk to expand obesity study into oral treatment
April 22, 2021Novo Nordisk, obesity
Novo Nordisk is planning to initiate a Phase IIIa study of oral semaglutide in obesity, expanding on its Phase IIIa …
Jubilant’s oral remdesivir formulation shows positive results in human trial
April 22, 2021COVID-19, Gilead, Jubilant Pharma, covid-19 treatment, pharma, pharma news, remdesivir
Jubilant Pharma has announced the successful completion of studies in human volunteers for their oral formulation of remdesivir – an …
UK Company launches COVID-19 neutralisation assay development kit
April 22, 2021COVID-19
The Native Antigen Company, a supplier of reagents for research into diagnostics and vaccines, have announced the launch of its …
Bharat Biotech jab shows 100% efficacy against severe COVID-19
April 22, 2021COVID-19, India
Indian biopharma company, Bharat Biotech, has reported interim analysis results from the Phase III trial of its COVID-19 vaccine, Covaxin, …
Pharmafile.com’s weekly COVID-19 news round-up
April 21, 2021Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news
The past week has seen lots of COVID-19 developments; Avacta’s 20-minute COVID test has gained clinical validation, the EMA has …
Amgen stomach cancer drug awarded Breakthrough Therapy Designation
April 21, 2021Research and Development Amgen, Cancer, cancer treatment, pharma, pharma news
Amgen’s investigational therapy, bemarituzumab, for certain types of stomach and esophagus cancer, has been granted Breakthrough Therapy Designation by the …
J&J COVID-19 vaccine to resume Europe rollout
April 21, 2021Research and Development COVID-19, COVID-19 vaccine, J&J, J&J vaccine, JJ, pharma, pharma news
The Johnson & Johnson COVID-19 vaccine will continue its rollout in Europe, following a review from the EMA.
GW Pharma’s cannabidiol gains EC approval
April 21, 2021Research and Development EC, EU, cannabis
GW Pharmaceuticals has received European Commission (EC) approval for the type II variation application for Epidyolex (cannabidiol), as an adjunctive …
UK Government launches COVID-19 Antivirals Taskforce
April 21, 2021Research and Development COVID-19, UK government
A new Antivirals Taskforce has been launched by the government to identify treatments for UK patients who have been exposed …
Adagio raises $336 million to advance COVID-19 antibody
April 20, 2021Manufacturing and Production Adagio, COVID-19, Financing, covid-19 treatment, pharma, pharma news
Adagio Therapeutics has financed $336 million to support the rapid advancement of their novel ADG20 antibody for the treatment and …
Oxford University & Prenetics to collaborate on global rapid testing tech
April 20, 2021Manufacturing and Production
The University of Oxford, Prenetics Limited and the Oxford Suzhou Centre for Advanced Research (OSCAR) have signed collaboration agreements to …
Enhertu now available via Cancer Drugs Fund following NICE decision
April 20, 2021Manufacturing and Production AstraZeneca, breast cancer, oncology
AstraZeneca and Daiichi Sankyo have announced that NICE has approved Enhertu (trastuzumab deruxtecan) for use within the Cancer Drugs Fund …
Novartis multiple sclerosis treatment recommended by NICE
April 20, 2021Manufacturing and Production NICE, Novartis, multiple sclerosis, pharma, pharma news
NICE have recommenced Novartis’ ofatumumab (Kesimpta) for the treatment of relapsing remitting MS (RRMS) in adult patients for use on …
Avacta’s COVID-19 lateral flow test gains clinical validation
April 20, 2021Manufacturing and Production COVID-19
Avacta have announced positive data from the clinical validation of its AffiDX SARS-CoV-2 antigen lateral flow test, based on a …
Lilly’s COVID-19 drug has EUA revoked in favour of combination therapy
April 19, 2021Sales and Marketing COVID-19, Eli Lilly, FDA, covid-19 treatment, lilly, pharma, pharma news
The FDA have revoked Emergency Use Authorization (EUA) of Eli Lilly’s bamlanivimab drug for the treatment of COVID-19, per the …
NICE launch ambitious five-year patient access strategy
April 19, 2021Sales and Marketing NICE
NICE has unveiled its five-year plan to speed up patients’ access to the latest and most effective treatments with increased …
Sanofi signs €414 million deal for C4XD oral IL-17A inhibitor programme
April 19, 2021Sales and Marketing Sanofi
Sanofi has signed an exclusive worldwide licensing agreement with C4X Discovery Limited for C4XD’s oral pre-clinical IL-17A inhibitor programme, which …
Sanofi multiple myeloma drug approved for second indication by EC
April 19, 2021Sales and Marketing European Commission, Sanofi, Sarclisa, pharma, pharma news
The European Commission (EC) has approved a second indication of Sanofi’s Sarclisa drug for the treatment of adult patients with …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
